A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts Meeting Abstract
| Authors: | Atkins, M. B.; Voss, M. H.; Plimack, E. R.; Rini, B. I.; Alter, R.; Dawson, N. A.; Beck, J. T.; Bhatt, R. S.; Pappas, K. M.; Wilson, D.; McClure, T.; Kumar, R.; Attie, K. M.; Sherman, M. L.; Pandya, S. S. |
| Abstract Title: | A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203371 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4566 |
| Notes: | Meeting Abstract: 4566 -- Source: Wos |
